IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
608.41
-10.51 (-1.70%)
At close: Mar 6, 2026, 4:00 PM EST
606.48
-1.93 (-0.32%)
After-hours: Mar 6, 2026, 6:29 PM EST

IDEXX Laboratories Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,3043,8983,6613,3673,215
Revenue Growth (YoY)
10.42%6.46%8.72%4.73%18.80%
Cost of Revenue
1,6441,5191,4711,3631,326
Gross Profit
2,6602,3792,1902,0041,889
Selling, General & Admin
1,0481,031901.89850.75796.4
Research & Development
251.21219.79190.95254.82161.01
Total Operating Expenses
1,3001,2511,0931,106957.4
Operating Income
1,3601,1281,097898.77932.03
Interest Income
3.0112.75.631.070.43
Interest Expense
-38.85-31.21-41.58-39.86-29.81
Total Non-Operating Income (Expense)
-35.84-18.51-35.95-38.79-29.37
Pretax Income
1,3241,1101,061859.97902.65
Provision for Income Taxes
264.73221.96216.13180.88157.81
Net Income
1,059887.87845.04679.09744.85
Minority Interest in Earnings
-----0
Net Income to Common
1,059887.87845.04679.09744.85
Net Income Growth
19.33%5.07%24.44%-8.83%28.03%
Shares Outstanding (Basic)
8082838485
Shares Outstanding (Diluted)
8183848587
Shares Change (YoY)
-2.67%-0.87%-0.73%-2.28%-0.17%
EPS (Basic)
13.1710.7710.178.128.74
EPS (Diluted)
13.0810.6710.068.038.60
EPS Growth
22.59%6.06%25.28%-6.63%28.17%
Free Cash Flow
1,057808.08772.88394.15636
Free Cash Flow Growth
30.82%4.55%96.09%-38.03%17.54%
Free Cash Flow Per Share
13.059.719.204.667.35
Gross Margin
61.80%61.04%59.82%59.52%58.76%
Operating Margin
31.60%28.95%29.97%26.69%28.99%
Profit Margin
24.62%22.78%23.08%20.17%23.17%
FCF Margin
24.56%20.73%21.11%11.71%19.78%
EBITDA
1,5051,2581,2121,0111,037
EBITDA Margin
34.97%32.28%33.11%30.01%32.24%
EBIT
1,3601,1281,097898.77932.03
EBIT Margin
31.60%28.95%29.97%26.69%28.99%
Effective Tax Rate
19.99%20.00%20.37%21.03%17.48%
Updated Feb 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q